Form 4: Bioventus Inc. SVP & General Counsel Sells Shares to Cover Taxes

Anthony D'Adamio, SVP & General Counsel of Bioventus Inc., sold 2,615 shares of Class A Common Stock to cover taxes upon the vesting of restricted stock units.

Summary

• On March 17, 2025, Anthony D'Adamio, the SVP & General Counsel of Bioventus Inc., sold 2,615 shares of Class A Common Stock.
• The sale was executed at a price of $9.75 per share.
• This transaction was made pursuant to a standing 10b5-1 instruction adopted on March 14, 2022, to cover taxes upon the vesting of restricted stock units on March 14, 2025.
• Following the transaction, D'Adamio directly owns 124,449 shares of Class A Common Stock.
• The shares were sold as part of a trade comprised of shares of multiple employees of the Issuer in multiple transactions at prices ranging from $9.56 to $10.00, inclusive.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations, executed under a pre-existing 10b5-1 plan. It doesn't necessarily reflect a positive or negative outlook on the company's future.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects. Sales to cover taxes on vesting equity are common and don't necessarily indicate a negative outlook.

Comparison to Industry Standards

• Insider sales, especially those executed under 10b5-1 plans, are a common occurrence across publicly traded companies.
• Companies like Medtronic and Stryker also see regular insider trading activity, often related to stock option exercises and tax obligations.
• The volume of shares sold by D'Adamio is relatively small compared to the total outstanding shares of Bioventus Inc., suggesting it's unlikely to have a significant impact on the stock price.

Stakeholder Impact

• The sale of shares by a company insider could be perceived negatively by some shareholders, but the impact is likely minimal given the context of the 10b5-1 plan and the relatively small number of shares involved.

Key Dates